Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TPX-112
- Development stage
- Preclinical
- Lead developer
- Tego Science
- Modality
- Autologous CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Patient-derived iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies, Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Topical
01
Overview
TPX-112 is an autologous cell therapy being developed by Tego Science for the treatment of oral mucosal defects. The therapy utilizes cultured mucosal cells derived from the patient's own tissue, which are expanded ex vivo and subsequently transplanted back into the patient to facilitate tissue regeneration and wound healing. By using autologous cells, the treatment aims to provide a biocompatible solution for repairing oral tissue damage while minimizing the risk of immune rejection. TPX-112 is currently in the preclinical stage of development.
- Other names
- autologous cultured mucosal cells
Beyond the preview
Go deeper on TPX-112.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TPX-112.